Metastatic pancreatic cancer represents the most advanced stage of a disease that has already spread beyond the pancreas to distant parts of the body. Understanding this condition, its mechanisms, and available support can help patients and families navigate one of the most challenging diagnoses in oncology.
Understanding Metastatic Pancreatic Cancer
Metastatic pancreatic cancer, also known as stage IV pancreatic cancer, occurs when cancer cells that originated in the pancreas have traveled to other organs or tissues far from where the disease began.[1] The pancreas is a gland located behind the stomach that produces digestive enzymes and hormones like insulin to regulate blood sugar.[2] When cancer develops and spreads from this organ, it most commonly reaches the liver, but can also affect the lungs, abdominal wall, bones, or distant lymph nodes.[3]
This form of cancer is considered unresectable, meaning it cannot be completely removed through surgery.[3] The cancer has either spread too far or involves critical blood vessels in ways that make surgical removal impossible. Despite being called “metastatic” or “advanced,” this does not mean death is immediate. Many patients live for months or even years with appropriate treatment and symptom management.[3]
Metastatic pancreatic ductal adenocarcinoma, often abbreviated as mPDAC, accounts for more than 90% of pancreatic cancer cases.[6] This is a particularly aggressive form that typically advances to metastatic stage either because of late diagnosis or limited response to initial treatments. The disease earns its reputation as lethal partly because the pancreas is surrounded by other organs including the small intestine, liver, and spleen, making early changes difficult to detect.[6]
Epidemiology: Who Gets Metastatic Pancreatic Cancer
Pancreatic cancer ranks as the seventh leading cause of cancer-related deaths worldwide.[1] Experts predict it will become the second leading cause of cancer death in Western countries within the next decades.[1] In 2020, an estimated 57,600 new cases were diagnosed in the United States alone.[1]
The five-year survival rate across all stages of pancreatic cancer combined stands at just 9%, making it the cancer type with the lowest survival rate.[1] For metastatic pancreatic cancer specifically, the five-year overall survival is even more devastating at approximately 2%.[1] The median survival expectancy with current treatments remains less than one year.[1]
Most cases of pancreatic cancer are diagnosed at an advanced stage, with the majority of patients already having metastatic or locally advanced disease by the time they seek medical care.[3] This late diagnosis pattern significantly contributes to poor outcomes. Pancreatic cancer rarely occurs before age 40, and more than half of all pancreatic adenocarcinoma cases occur in people over 70 years old.[5]
Cases of pancreatic cancer are rising. Current trends indicate that both new diagnoses and deaths from pancreatic cancer will more than double by 2030.[12] Globally, an estimated 460,000 people are diagnosed each year, with approximately 430,000 deaths worldwide attributed to the disease.[12]
Causes and Risk Factors
Pancreatic cancer develops when certain changes occur in the way pancreatic cells function, particularly how they grow and divide into new cells.[2] These cancerous cells have the ability to invade other parts of the body, leading to metastatic disease.[5] The disease is hyperaggressive and evolves from non-invasive precursor lesions, which explains why only minor symptoms may appear initially.[1]
Several risk factors increase the chance of developing pancreatic cancer, though having these risk factors does not guarantee someone will get the disease. Many people with risk factors never develop pancreatic cancer, while others with no known risk factors do.[2]
Tobacco smoking is one of the most significant modifiable risk factors. About 25% of pancreatic cancer cases are linked to smoking.[5] The risk applies to cigarettes, cigars, and other forms of tobacco use.[7] Other changeable risk factors include having excess body weight, which can contribute to disease development.[2]
Health conditions also play a role in risk. Having a personal history of diabetes or chronic pancreatitis increases the likelihood of developing pancreatic cancer.[2] New research has discovered that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer beyond any single factor alone.[4] Some healthcare providers may suspect pancreatic cancer if a patient has recently developed diabetes or pancreatitis, which is a painful condition caused by inflammation in the pancreas.[7]
Genetic factors cannot be changed but are important to understand. Having a family history of pancreatic cancer or pancreatitis increases risk.[2] Certain hereditary conditions significantly raise the chances of developing the disease. These include hereditary nonpolyposis colon cancer (also called Lynch syndrome), Peutz-Jeghers syndrome, hereditary breast and ovarian cancer syndrome, familial atypical multiple mole melanoma (FAMMM) syndrome, and ataxia-telangiectasia.[2]
Symptoms of Metastatic Pancreatic Cancer
One of the greatest challenges with pancreatic cancer is that it typically causes no symptoms in its early stages, making detection extremely difficult.[2] Symptoms that are specific enough to suggest pancreatic cancer usually do not develop until the disease has reached an advanced stage.[5] By the time symptoms appear and diagnosis occurs, the cancer has often already spread to other parts of the body.[5]
The most common symptom is feeling tired and generally unwell.[18] As the disease progresses, people may notice upper abdominal pain that can spread to the back.[6] This pain can come and go at first but may worsen after eating meals or when lying down.[7]
Jaundice, which is yellowing of the skin and the whites of the eyes, is a notable symptom.[2] This occurs when the cancer blocks the bile duct, preventing bile from flowing properly. Along with jaundice, patients may experience itchy skin, light-colored stools, and dark-colored urine.[2]
Unexplained weight loss is common, often accompanied by loss of appetite.[2] Many patients report they simply do not feel like eating, which could be due to the cancer itself or treatments being received.[18] Nausea and vomiting may also occur, along with changes in bowel movements.[2]
Additional symptoms specific to advanced pancreatic cancer include fatigue, bloating, and gas.[7] Some people develop blood clots, which can be an unusual sign of the disease.[6] A person with advanced pancreatic cancer may also experience ascites, which is a buildup of fluid in the abdomen.[3]
It is important to note that many of these symptoms are vague and unexplained, meaning they could be caused by many other conditions.[3] However, if you are experiencing one or more of these symptoms, you should speak to your doctor immediately and specifically reference pancreatic cancer as a possibility.[3]
Prevention and Early Detection Challenges
Learning about risk factors for pancreatic cancer can help people make changes that might lower their risk of getting the disease.[2] Some risk factors, like smoking, can be changed. Quitting tobacco use, maintaining a healthy body weight through diet and physical activity, and managing conditions like diabetes may help reduce risk.[2]
Unfortunately, pancreatic cancer is notoriously difficult to diagnose early.[2] Early-stage pancreatic tumors do not show up well on standard imaging tests.[7] There is currently no widely used method for early detection of the disease, and few patients diagnosed with pancreatic cancer have identifiable risk factors.[12]
The disease often develops without early symptoms, and the pancreas is located deep in the body where physical examination cannot detect problems.[12] By the time symptoms develop that prompt someone to see a doctor, the cancer has frequently already reached an advanced or metastatic stage. This timing makes prevention and early detection one of the most challenging aspects of pancreatic cancer care.
How Metastatic Pancreatic Cancer Develops: Understanding Pathophysiology
The vast majority of pancreatic cancers, about 95%, begin in exocrine cells, which are the cells that produce digestive juices.[2] Pancreatic adenocarcinoma, which accounts for about 90% of cases, starts within the part of the pancreas that makes these digestive enzymes.[5] Most pancreatic cancers begin in the ducts of the pancreas, specifically in the cells that line these passageways.[7]
At the cellular level, pancreatic cancer arises when cells in the pancreas mutate, meaning their genetic material changes, causing them to multiply out of control and form a mass or tumor.[7] These cancerous cells develop the dangerous ability to invade other parts of the body, which is what defines metastatic spread.[5]
The process of metastasis involves cancer cells breaking away from the original tumor in the pancreas and traveling through the bloodstream or lymphatic system to other organs.[1] The liver is the most common site for pancreatic cancer to spread because of the blood flow patterns between the pancreas and liver. However, cancer cells can also reach the lungs, establish themselves within the abdominal cavity, spread to faraway lymph nodes, or rarely reach the bones.[3]
Even when pancreatic cancer spreads to another area of the body, it is still called pancreatic cancer because that is where it originated.[3] For instance, pancreatic cancer that has spread to the liver is not liver cancer, but metastatic pancreatic cancer in the liver. This distinction is important because the treatment approach is based on the original cancer type, not where it has spread.
Several biological mechanisms drive the metastatic process in pancreatic cancer. Research has identified signaling pathways, such as epithelial-mesenchymal transition, NF-κB, and KRAS mutations, that play roles in how pancreatic cancer cells gain the ability to spread.[1] Understanding these molecular mechanisms presents formidable challenges but also offers insight into promising therapeutic targets for the future.
Diagnosis and Staging
Imaging studies are the only way to visualize a pancreatic tumor.[3] Doctors commonly use a computed tomography scan, also called a CT scan, to see if cancer has spread to nearby organs.[3] Other tests such as magnetic resonance imaging (MRI), positron emission tomography (PET), and endoscopic retrograde cholangiopancreatography (ERCP) may be used, though these are less common than CT scans.[3]
Before moving forward with treatment, it is critical to understand as much about each person’s cancer as possible.[17] This means capturing the full picture from the time of diagnosis and beyond. In most instances, a CT scan or MRI scan identifies the location of the cancer and possible spread, but standard scans are just one piece of the puzzle.[17]
PET scans and additional molecular testing play important roles in accurately staging the cancer and assessing its behavior.[17] They can help determine if treatment is working effectively to shrink the tumor, whereas traditional CT scans have distinct limitations in assessing response in pancreatic primary tumors. If healthcare teams see the response they are anticipating on a PET scan, those are the patients that tend to do very well. If they are not seeing a response, they may need to switch therapies to achieve better outcomes.[17]
Novel genetic testing developed at specialized centers can test the blood of patients, as well as fluid from the abdomen through a procedure called laparoscopy, to detect cancer DNA.[17] This method helps experts determine who might be at risk for pancreatic cancer recurrence and individualize treatment to reduce the risk of the cancer returning.
Pancreatic cancer is categorized into five different stages depending on the size and location of the tumor and whether the cancer has spread.[6] Stage IV, also known as metastatic cancer, means the cancer has spread to distant areas in the body such as the liver, lungs, or abdominal cavity.[6] At this stage, the cancer is defined as advanced and is considered unresectable.[3]
